The Vancouver-based biotech firm aims to nearly double its headcount and expand its R&D efforts to find antibodies to treat disease.
AbCellera Raises $105 Million To Boost Drug Discovery Against Coronavirus And Other Diseases
The Vancouver-based biotech firm aims to nearly double its headcount and expand its R&D efforts to find antibodies to treat disease.